2019.03.001. Epub 2019 May 30.PMID: 31153743 2019 Diagnosing Alpha-1-Antitrypsin Deficiency Using A PCR/Luminescence-Based Technology. Veith M, Klemmer A, Anton I, El Hamss R, Rapun N, Janciauskiene S, Kotke [...] the development and progression of lung and liver diseases. Pharmaceutical companies are currently testing novel approaches in patient cohorts, such as inhibiting the formation of the mutated misfolded AAT [...] lung and liver disease development and progression. Currently, companies in patient cohorts are testing novel approaches, one of which is to silence in the liver the production of the mutant misfolded
Ganzenmueller T, Kluba J, Becker JU , Bachmann O, Heim A: Detection of cytomegalovirus (CMV) by real-time PCR in fecal samples for the non-invasive diagnosis of CMV intestinal disease. J Clin Virol 2014; 61(4): [...] Rüschoff J, Kreipe HH : [Determination of tumor biological parameters in breast cancer: round robin testing for quality assurance]. Pathologe 2014; 35(1): 61-71 [German] Linkermann A, Skouta R, Himmerkus N
Sanfeliu E, Parker JS, Perou CM, Villagrasa P, Prat A, Sharma P, and Harbeck N (2025). TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy. Ann Oncol [...] Kolberg-Liedtke C, Feuerhake F, Kreipe HH, Nitz U, and Harbeck N* (2022). Impact of RNA signatures on pCR and survival after 12-week neoadjuvant pertuzumab plus trastuzumab with or without paclitaxel in the
05.004. Epub 2022 May 29. PMID: 35649494 Free article. Combination of PI-RADS score and mRNA urine test-A novel scoring system for improved detection of prostate cancer. Katzendorn O, von Klot CAJ, Mahjoub [...] abstract available. [The molecular pathology breviary: what do hybrid capture, anchored multiplex PCR and amplicon-based mean?] Lehmann U, Stenzinger A. Pathologe. 2022 May;43(3):229-230. doi: 10.1007 [...] article. Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing. Neumann O, Burn TC, Allgäuer M, Ball M, Kirchner M, Albrecht T, Volckmar AL, Beck S, Endris V,
K., Kempf, H., Zweigerdt, R. , and Mandenius, C. F. 2016. A Microfluidic Bioreactor for Toxicity Testing of Stem Cell Derived 3D Cardiac Bodies. Methods Mol Biol 1502:159. https://doi.org/10.1007/7651_2016_340 [...] 2015. Stem cell derived in vivo-like human cardiac bodies in a microfluidic device for toxicity testing by beating frequency imaging. Lab Chip 15, no. 15:3242. *Authors contributed equally. Effenberg, [...] T., and Martin, U. 2014. Efficient designer nuclease-based homologous recombination enables direct PCR screening for footprint less targeted human pluripotent stem cell clones. Stem Cell Reports 2, no.
Walter U (2024). Evidence Register Green List Prevention - Analysis of the listed effectiveness-tested programs. Public Health 2024; 86: 474-482. DOI 10.1055/a-2308-7256 Brinkhuis F, Julian E, van den [...] Rebentisch-Krummhaar B, Beume D, Klawunn R , & van Eickels H (2023). They'll grow into it! Or do they? - Testing a blended learning module to support the use of new technical products in everyday nursing care. [...] House; Doc23dkvf529. doi: 10.3205/23dkvf529. Oedingen C , Bartling T , Schrem H, Krauth C (2023). PCR266 Transplant physicians' preferences in deceased organ allocation: a pilot discrete choice experiment
COVID-19 / SARS-CoV-2 Research at the MHH Research group of Prof. Dr. Reinhold Förster develops a simple test to detect protective neutralizing antibodies. COVID-19 / SARS-CoV-2 Research at the MHH From basic [...] A, Pink I, Witte T, Wetzke M, Ernst D, Jablonka A, Happle C. Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals. Infect [...] nández M, Kaiser FK, Rimmelzwaan G, Osterhaus A, Blume C. Combined Prospective Seroconversion and PCR Data of Selected Cohorts Indicate a High Rate of Subclinical SARS-CoV-2 Infections-an Open Observational